1 The effects of 5-hydroxytryptamine (5-HT) were investigated on right atrial appendages obtained from patients treated with f-adrenoceptor blocking agents who were undergoing open heart surgery. Atrial strips were paced under isometric conditions. 2 5-HT increased contractile force to approximately one half of the force produced by a saturating concentration of (-)-isoprenaline. Both 5-HT and (-)-isoprenaline accelerated the onset of relaxation, as indicated by an abbreviation of time to peak force.
Introduction
There is a bewildering heterogeneity of heart 5-hydroxytryptamine (5-HT) receptors among species (see . 5-HT increases myocardial contractions of molluscs (Greenberg, 1960) through receptors possibly positively coupled to adenylyl cyclase (Sawada et al., 1984) . 5-HT increases ventricular contractile force and prolongs action potentials in feline (Kaumann 1983; and guinea-pig hearts through unknown receptors. 5-HT increases the contractile force of cat atria through nonclassified receptors (Kaumann, 1983; . In rabbits 5-HT causes positive inotropic effects mainly indirectly through a release of noradrenaline (Trendelenburg, 1960; Fozard, 1984) . 5-HT causes tachycardia perhaps through 5-HT2 receptors (Peroutka & Snyder, 1979) in rat (Docherty, 1987) or 5-HT1-like receptors (Bradley et al., 1986) in cat (Saxena et al., 1985-but see Kaumann, 1986 ) and through unknown receptors in pig (Bom et al., 1988) and guinea-pig (Walter et al., 1984) .
We now describe some characteristics of a 5-HT receptor in human atrium. Progress reports of this work have been presented (Kaumann et al., 1989b; .
Methods

Patients
Right atrial appendages were obtained from 49 patients (39 males, 10 females) , undergoing open heart surgery, 47 with coronary heart disease receiving coronary artery bypass grafts and 2 with aortic valve disease. The average age of the patients was 59 + 1 years for the whole group, 58 + 1 years Author for correspondence.
for the males and 63 + 2 years for the females. All the patients had been receiving fi-adrenoceptor blocking agents daily for more than 2 months, up to and including the day of operation. The fl-blockers were primarily atenolol (28) and metop- rolol (10); on occasion individual patients were taking acebutolol (3), propranolol (2), bisoprolol (1), sotalol (1), nadolol (1), oxprenolol (1), timolol (1), labetalol (1). Some patients had also been receiving diuretics, nitrates, calcium channel antagonists, antacids, captopril, enalapril, bezafibrate, clofibrate. Anaesthesia was induced with thiopentone and midazolam and maintained with fentanyl and trichloroethylene; atracurium was used as muscle relaxant.
Isolated atrial strips
The tissues were dissected and set up as described by Gille et al. (1985) . After excision, the right atrial appendages were immediately placed in an oxygenated solution at room temperature containing (mM): Na+ 125, K+ 5, Ca2+ 2.25, Mg2+ 0.5, Cl-98.5, SO2-0.5, HCO-29, HPO2-1, EDTA 0.04. Tissues were continuously oxygenated until dissection. Dissection was at room temperature and started within 120min of surgical removal. Each atrial appendage was usually cut into 4 strips. The strips were trimmed to a thickness < 1 mm to facilitate diffusion of oxygen and drugs. The tissues were mounted, on occasion in pairs, (usually from different patients), in a 50ml organ bath and apparatus described by Blinks (1965) . The organ bath contained a solution at 37°C of the above composition supplemented with (mM): Na' 15, fumarate 5, pyruvate 5, L-glutamate 5, glucose 10 and ascorbate 0.2. The solution was gassed with 95% 02 and 5% CO2. The water used was deionised and twice distilled in glass.
Each strip was attached to a strain-gauge transducer and driven at 2s intervals with a square-wave pulse of 5 ms duration and of just over threshold voltage. After the determination of a length-force curve, the length of each strip was set Br. J. Pharmacol. (1990), 100, 879-885 at 50% of the resting tension associated with maximum developed force (Kaumann, 1972) . Contractile force was recorded on a chart recorder. Fast speed recordings (100mms~1) were used to measure time to peak force ( Figure 1 ).
Concentration-effect curves and calculations
The inotropic potency of 5-HT was estimated from cumulative concentration-effect curves. Only a single curve for 5-HT was determined per tissue. All experiments were terminated by the administration of a saturating concentration of (-)-isoprenaline (200pM). The inotropic effects of the different concentrations of 5-HT were expressed as percentages of the maximum effect of 5-HT. The maximum inotropic effect of 5-HT was estimated as a percentage of the (-)-isoprenalineinduced effect. -log EC10, EC30, EC50, EC70 and EC90 values were determined from the concentration-effect curve of each individual experiment by interpolation and the mean + s.e.mean of the log values from all the experiments was calculated for each effect level.
Whenever antagonists were used, they were present for at least 45 min before the concentration-effect curve for 5-HT was determined. Phenoxybenzamine was an exception, being incubated for 30 min. Competitive antagonism of the inotropic effects of 5-HT was analysed by the equation of Arunlakshana & Schild (1959) .
Biochemical assays
Adenosine 3':5'-cyclic monophosphate (cyclic AMP-dependent protein kinase activity and cyclic AMP levels were determined in freeze-clamped atria. The tissues were homogenized in 20 volumes of buffer containing NaCl 100mm, NaPO4 10mM, isobutyl methyl xanthine (IBMX) 0.5 mm, EDTA 10mM (pH 6.8) with a Polytron-Brinckman (position 8, 5 s). The homogenate was centrifuged at 6000 g for 5min at 40C. Supernatants, containing soluble protein kinase, were incubated for 2min at 300C with [32P]-y-ATP 300pM, Na2HPO4 50mM (pH 6.8), MgCI2 10mM, EGTA 1mm and malantide 20pM in the presence and absence of 2pM cyclic AMP, as described by Murray et al. (1990) . The activity ratio was obtained by dividing the counts measured in the absence of cyclic AMP by those measured in its presence. The activity ratio measures the proportion of cyclic AMP-dependent protein kinase active in the atrium. Soluble cyclic AMP was determined in this sample by radioimmunoassay. Protein was determined by the method of Bradford (1976 The 5 The maximum inotropic effect of 5-HT was approximately one half of that of 200gM (-)-isoprenaline (Table 1) .
A series of blocking agents did not significantly modify the potency and maximum inotropic effects of 5-HT (Table 1 ). An exception was ICS 205930 (22AM) which caused surmountable antagonism (Table 1 and blocked the positive inotropic responses to (-)-isoprenaline. Atrial appendages from 3 patients were each divided into 2 strips; one strip was exposed to 3juM ICS 205930 for 1 h, the other to solvent. A cumulative concentration-effect curve for (-)isoprenaline was then determined, starting at 0.2 nm and ending at the concentration producing a maximum inotropic effect. ICS 205930 did not affect the responses to (-)-isoprenaline. The pEC50 (I + s.e.mean) for (-)-isoprenaline was 8.0 + 0.1 and 8.1 + 0.1 in the absence and presence of ICS 205930 respectively. Potentiation by cocaine 5-HT is taken up by tissues in a cocaine-sensitive manner (Thoa et al., 1969; Fukuda et al., 1986) . Blockade of 5-HT uptake by cocaine may make more 5-HT available to the receptors and thus cause potentiation. We therefore investigated the effects of cocaine. Cocaine caused a six fold potentiation of the positive inotropic effects of 5-HT ( Figure 3 , Table 1 ). In some tissues cocaine slightly increased basal contractile force, an effect not observed in the presence of 1 fM (-)-pindolol. Potentiation of the 5-HT effects by cocaine was also observed in the presence of 1flM (-)-pindolol ( Figure 3 , Table 1 ).
Competitive blockade by ICS 205930
The blocking effects of ICS 205930 were observed also in the presence of 6puM cocaine and 1 fM (-)-pindolol ( Figure 4 , Table 1 ). The antagonism was concentration-dependent, yielding a Schild-plot with a slope not significantly different from 1 (Figures 4, 5 ).
An equilibrium dissociation constant (-log M (pKB)) of 6.7
was estimated for the ICS 205930/5-HT receptor complex. As can be seen from Figure 5 this was independent of the presence of 6 fiM cocaine.
Increase in cyclic AMP levels and protein kinase activity An untreated tissue, a (-)isoprenaline-treated tissue and a 5-HT-treated tissue obtained from the same patient were freeze clamped. The tissues were frozen after equilibrium responses to the amines had been reached (Figure 1 ). Biochemical assays revealed that 10pUM 5-HT both increased cyclic AMP levels and stimulated cyclic AMP-dependent protein kinase activity ( Figure 6 ). 
Discussion
Effect of 5-hydroxytryptamine uptake blockers
We have described a potent positive inotropic effect of 5-HT on human atrium. Cocaine potentiated the inotropic effect of 5-HT, presumably by preventing neuronal (Thoa et al., 1969; Paiva et al., 1984) and/or extraneuronal (Paiva et al., 1984; Fukuda et al., 1986 ) uptake of 5-HT, thereby making more 5-HT available at the receptors. In some tissues cocaine slightly enhanced basal contractile force, probably by preventing reuptake of noradrenaline released from nerve endings (Iversen, 1967) pindolol. (-)-Pindolol did not prevent the potentiating effects of cocaine. The inotropic potency of 5-HT (pEC50 = 7.4, this paper) on human atria is five times greater than that of (-)-noradrenaline (pEC50 = 6.6) (Gille et al., 1985; Kaumann et al., 1989a) in the absence of tissue uptake of the amines. The difference in potency between 5-HT and (--noradrenaline was also observed when amine uptake was not blocked (pEC50 = 6.6 for 5-HT, this paper; and pEC50 = 5.8 for (-)-noradrenaline, Gille et al., 1985) . It is likely that 6pM cocaine, used in our experiments, caused maximum potentiation of the inotropic effects of 5-HT by nearly saturating 5-HT uptake. Some evidence (Hyttel, 1982) supports our assumption that 6pM cocaine causes near maximum inhibition of 5-HT uptake. In rat brain, Hyttel (1982) showed that cocaine prevents 5-HT uptake with an IC5o of 0.26puM. Assuming that cocaine acts by competing with 5-HT, this IC50 will be approximately equal to the Ki for cocaine since in the experiments of Hyttel the 5-HT concentration was well below its Km. In the present experiments, the uptake carrier also appears not to be saturated by 5-HT even at the high concentrations used to surmount antagonism by ICS 205930 since the blocking potency was the same in the presence and absence of 6 uM cocaine ( Figure 5 ). Assuming a Ki of 0.26pM, this concentration of cocaine would produce more than 95% inhibition of the neuronal uptake mechanism.
Phenoxybenzamine has been reported to be a weak blocker (IC50 = 13.5 pM) of 5-HT uptake into human platelets, a system which resembles neuronal uptake (Ahtee & Saarnivaara, 1971 ). We did not observe significant 5-HT potentiation with 10pM phenoxybenzamine, presumably because under our conditions 5-HT uptake was insufficiently blocked.
Nature of the receptor
Which receptor mediates the positive inotropic effects of 5-HT? The participation of a variety of receptors can be excluded because appropriate blocking agents, at concentrations that nearly saturate these receptors, did not significantly modify the atrial 5-HT responses (Table 1) .
(1) fill f2 or fl3-Adrenoceptors could be involved either through direct interaction with 5-HT or through interaction with noradrenaline released by 5-HT. However, we discard these possibilities because the fi-adrenoceptor antagonists (±)-propranolol 0.4,uM and (-)-pindolol 1 M were ineffective. pKB values for (-)-propranolol of 8.6 and 9.0 have been estimated for PB-and 92-adrenoceptors respectively of human atrium (Gille et al., 1985) . pKB values for (--pindolol of 9.3 and 8.9 have been reported for fil-and f2-adrenoceptors in human atrium (Kaumann & Lobnig, 1986) . A pKD of 8.0 has been estimated for pindolol in fat cell 3-adrenoceptors (Emorine et al., 1989) ; these receptors could be involved in the cardiostimulant effects of certain indole amines (Kaumann, 1989) .
(2) 5-HTlA receptors can be discounted because 1 pM (-)-pindolol was ineffective. A pKD value of 7.7 has been estimated for 5-HTlA receptors in pig cortex (Hoyer, 1989 (Hoyer, 1989 (Hoyer, 1989) . (5) 5-HT1-like receptors can be excluded because methysergide and methiothepin, known to block these receptors (Bradley et al., 1986) , were ineffective. (6) 5-HT2 receptors are not involved because 0.4 pAs ketanserin, 4pM yohimbine, 1 FM methysergide, 10pM phenoxybenzamine (30 min) were ineffective. pKB estimates for smooth muscle 5-HT2 receptors are 9.4-9.6 for ketanserin (Frenken & Kaumann, 1984; Kaumann & Frenken, 1985; Lemoine & Kaumann, 1986) , 7.2 for yohimbine (Kaumann, 1983) and 9.0 for methysergide . Phenoxybenzamine, as used under our conditions, irreversibly blocks 5-HT2 receptors (Clancy & Maayani, 1985; Frenken & Kaumann, 1987) . (7) 72222 (7.9 vagus, 9 .3 sympathetic nerves) and granisetron (9.9 vagus, 10.7 sympathetic nerves) (Fozard 1989) . The experiments with the series of antagonists that have been discussed were carried out in the absence of cocaine. It could, therefore, be possible that one or more of these antagonists did block the inotropic effects of 5-HT through receptors but that this was obscured by a simultaneous inhibition, by the antagonist, of 5-HT uptake by atrial nerves. This seems unlikely, as to obtain the results in Table 1 , exactly equal effects on the receptor and 5-HT uptake carrier would be required; also none of the antagonists used are reported 5-HT uptake inhibitors.
Blockade of 5-HT uptake by an antagonist would have made more 5-HT available to 5-HT receptors and so potentiated the positive inotropic effect of 5-HT. The following argues against this. As discussed above it can be assumed that 6plM cocaine causes near maximal blockade of 5-HT uptake.
Hence, the maximum potentiating effect of any uptake inhibitor is the same as that of cocaine (i.e. 6 fold, Figure 3 ). The concentrations of the antagonists used are many more than 6 times their respective reciprocal affinities. The high antagonist concentrations used should therefore still have caused blockade if the respective receptors were involved. This was not observed.
ICS 205930 was the only antagonist found to block competitively the positive inotropic effects of 5-HT. This blockade was specific to 5-HT as neither basal force nor fi-adrenoceptor-mediated responses to (-)-isoprenaline were changed. The blockade by ICS 205930 was not different in the presence or absence of cocaine suggesting that the neuronal capture of 5-HT did not distort antagonism at least in the 5-HT concentration range used. The blocking potency of ICS 205930 on human atrium is inconsistent with its high affinity for 5-HT3 receptors (pA2 values 10.2-10.6; Fozard, 1989) . Our estimated pKB value of 6.7 is similar to pKB values of ICS 205930 for rodent brain 'so called' 5-HT4 receptors positively coupled to adenylyl cyclase (pKB = 6.2, Dumuis et al., 1988; and for intestinal 5-HT receptors that mediate release of acetylcholine (pKB = 6.4, Craig & Clarke, 1989) . This evidence, taken together with the increase in cyclic AMP levels we found, suggests, but does not prove, that human atrial 5-HT receptors resemble rodent cerebral 'so called' 5-HT4 receptors and perhaps some intestinal 5-HT receptors.
Nature of the transduction mechanism
We have shown that 5-HT enhances contractile force and hastens relaxation. These effects are characteristic of agents that increase myocardial cyclic AMP and indeed we have provided evidence that 5-HT increases cyclic AMP levels and stimulates cyclic AMP-dependent protein kinase activity. Similar inotropic and biochemical effects are also caused by (-)-isoprenaline and other catecholamines. Both effects can be mediated either through fl1-adrenoceptors ((-)-noradrenaline) or through f2-adrenoceptors ((-)-adrenaline) in human atrium (Kaumann et al., 1989a; Hall et al., 1990) . We therefore suggest that 5-HT and catecholamines share a common biochemical pathway in human atrium. The pathway is likely to consist of a Gs transducer protein that is activated to stimulate adenylyl cyclase by a receptor-ligand complex with 5-HT or by a complex of a catecholamine with a fl1-or 112-adrenoceptor. The cyclic AMP formed specifically activates the cyclic AMP-dependent protein kinase which subsequently phosphorylates proteins involved in the contraction and relaxation processes (England, 1983) . Phosphorylation of membrane Ca2+ channels increases the Ca2+ influx which may enhance contraction either directly or indirectly by inducing Ca2 + release from internal stores (Reuter, 1983) . Phosphorylation of phospholamban causes faster pumping back of Ca2+ into stores, hastening relaxation (Tada & Katz, 1982) . Phosphorylation of troponin I decreases the affinity of troponin C for Ca2 , thereby also contributing to the acceleration of the onset of relaxation (England, 1983) .
Conclusion
The transduction mechanism of human atrial 5-HT receptors probably resembles that of rodent cerebral 'so called' 5-HT4 receptors (Dumuis et al., 1988; 
